Medicus Pharma Ltd.
MDCX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001997296
No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesMDCXW
13F holders, Q3 2025
Institutional positions in Medicus Pharma Ltd. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −1 vs. Q2 2025
- Shares held
- 2.12M
- −86.6K (−3.9%) vs. Q2 2025
- Total value
- $4.91M
- −$1.69M (−25.6%) vs. Q2 2025
- New holders
- 7
- 3 more added
- Sold out
- 8
- 5 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.18M |
| Q1 2026 | 21 | $301.6K |
| Q4 2025 | 21 | $6.03M |
| Q3 2025 | 20 | $4.91M |
| Q2 2025 | 21 | $6.60M |
| Q1 2025 | 7 | $11.4M |
| Q4 2024 | 3 | $3.74M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Medicus Pharma Ltd.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 75 | $174 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 222 | $514 | 0.00% | +222 | New |
| EverSource Wealth Advisors, LLC | 300 | $695 | 0.00% | +300 | New |
| DAGCO, Inc. | 349 | $808 | 0.00% | −1−0.3% | Reduced |
| Jones Financial Companies LLLP | 400 | $1.05K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 1,000 | $2.00K | 0.00% | +1,000 | New |
| Larson Financial Group LLC | 1,000 | $2.31K | 0.00% | −2,125−68.0% | Reduced |
| Morgan Stanley | 5,968 | $13.8K | 0.00% | −5,762−49.1% | Reduced |
| UBS Group AG | 6,957 | $16.1K | 0.00% | −23,969−77.5% | Reduced |
| Commonwealth Equity Services, LLC | 10,882 | $25.0K | 0.00% | +10,882 | New |
| Base Wealth Management LLC | 11,543 | $26.7K | 0.02% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 14,000 | $31.4K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 16,216 | $37.5K | 0.00% | +452+2.9% | Added |
| May Hill Capital, LLC | 17,811 | $41.2K | 0.01% | −17,811−50.0% | Reduced |
| LPL Financial LLC | 18,751 | $43.4K | 0.00% | +18,751 | New |
| Brave Asset Management Inc | 20,000 | $46.3K | 0.01% | +20,000 | New |
| Bryn Mawr Trust Co | 25,622 | $59.3K | 0.00% | +25,622 | New |
| Private Advisor Group, LLC | 151,500 | $350.7K | 0.00% | +5,500+3.8% | Added |
| Yorkville Advisors Global, LP | 230,000 | $532.5K | 0.21% | +124,160+117.3% | Added |
| Interchange Capital Partners, LLC | 1,586,871 | $3.67M | 0.72% | 00.0% | Unchanged |
| Guyasuta Investment Advisors Inc | 0 | $0 | 0.00% | −76,911−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −53,385−100.0% | Sold out |
| SeaCrest Wealth Management, LLC | 0 | $0 | 0.00% | −46,624−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −41,099−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,788−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,099−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −400−100.0% | Sold out |